We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Activeops Plc | LSE:AOM | London | Ordinary Share | GB00BLH37Y17 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 112.50 | 110.00 | 115.00 | 112.50 | 112.50 | 112.50 | 208,093 | 07:44:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Cmp Integrated Sys Design | 26.77M | 845k | 0.0118 | 95.34 | 80.28M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/11/2024 15:38 | ActiveOps (AOM) Interim results presentation - November 2024 ActiveOps Executive Chair, Richard Jeffery and CFO, Emma Salthouse present the group’s results for the six months ended 30 September 2024. Watch the video here: Or listen to the podcast here: | tomps2 | |
14/11/2024 07:11 | Interim Results for the 6 months ended 30 September 2024 Revenue ActiveOps' ARR at 30 September 2024 totalled £26.15m (30 September 2023: £23.73m), representing year-on-year growth of 10%. The successful launch of ControliQ Series 3 in September 2023 has bolstered the ARR growth in the first half of the year with upsell to multiple customers, compounded by new customer wins. This strong upsell performance is anticipated to continue in the second half of the year, during which a high proportion of renewals take place. On a constant currency basis, the ARR growth exceeded 12%. Total revenue for the Group at £14.32m (H1 FY24: £13.06m) is 10% ahead of the same period last year, with recurring software and subscription revenues increasing by 11% to £12.96m (H1 FY24: £11.72m) on a reported basis. Training and Implementation ('T&I') revenue at £1.36m (H1 FY24: £1.34m) was in-line with the prior year. Margins and operating profit Gross profit margins have remained in line with prior year at 84% (H1 FY24: 84%). Software and Subscription margins marginally increased to 88% (H1 FY24: 87%), due to prudent cost management. Operating expenses (excluding share-based payments, depreciation and amortisation) increased by 7% to £10.92m (H1 FY24: £10.17m). This is primarily due to the investment in our global sales operation. Adjusted EBITDA increased to £1.04m (H1 FY24: £0.79m), reflecting revenue growth and good cost control. Statutory Results The Group reported a profit before tax for the period of £0.47m (H1 FY24: £0.10m). Earnings per Share Basic Earnings per Share for continuing operations was a profit of 0.52p (H1 FY42: loss of 0.14p). Cash flow As is typical for the business, cash flow from operations in the first half of the year was negative £4.32m (H1 FY24: (£5.35m)). The negative cashflow position in H1 is attributable to the phasing of renewals over the year, and the timing of invoices raised. A significant level of renewals take place in the second half of the year and the timing of payments of annual in advance bills significantly impacts the cash position at 30 September 2024. Balance Sheet The Group has maintained a strong balance sheet position with cash and cash investments of £13.44m (H1 FY24: £9.90m) and net assets of £9.29m (FY24: £8.80m). Current Trading and Outlook The second half has begun well, with the signing of two new engagements, with a multinational BPO and a well-known global healthcare company, which is also the first customer to contract for ControliQ Series 4. Both engagements have significant expansion potential given the size of the organisations. Whilst the reduction within one customer will impact exit ARR at the year end, we see a range of expansion opportunities elsewhere and the business continues to trade in line with full year expectations. Looking ahead, we are confident the investment into our sales team, and the growing AI capabilities of our platform, provide us with a fantastic springboard for growth in FY26 and beyond. Richard Jeffery, Executive Chair | masurenguy | |
17/10/2024 06:54 | That's very good. But it is merely a copy & paste of thr RNS. What's your point? | macarre | |
17/10/2024 06:43 | Trading Update and Notice of Half Year Results ActiveOps plc provides an update on trading for the six months ended 30 September 2024. The Board is pleased to report that the Company has delivered good revenue and profit growth in the first half of the year and is trading in line with full year expectations. FY25 H1 Financial Highlights The Group expects to report overall revenue growth of approximately 9%, or 11% on a constant currency basis ("CC"), to £14.3m (H1 2024: £13.1m), including 10% growth in SaaS revenue (11% on a CC basis) to £13.0m (H1 2024: £11.8m). ARR increased 11% (12% on a CC basis) to £26.2m (30 September 2023: £23.7m), and NRR increased to 108% (H1 2024: 104%). With this solid revenue performance, the Group expects to deliver EBITDA growth for the half and an increase in profit before tax. ActiveOps remains well capitalised and highly cash generative, with cash and cash investments at the period end of £13.4m (H1 2024: £9.9m). ActiveOps Executive Chair, Richard Jeffery commented: "ActiveOps continues to deliver for our customers, and I am pleased with the progress achieved so far this year. AI has the potential to transform service operations, and our platforms and people are at the forefront of making that a reality for our customers. While cognisant of the ongoing challenging market environment, the strength of our offering, customer base and balance sheet provide us with confidence to invest in our sales team as we seek to accelerate our organic growth rate and remain focused on converting the opportunity at hand." The Company intends to announce its results for the six months ended 30 September on 14 November. | masurenguy | |
17/9/2024 20:16 | At 16:15 Columbia Threadneedle manager James Thorne sings his praises: | rambutan2 | |
17/9/2024 16:01 | Top 9 investors hold circa 72% of the issued shares as at 17th September 2024. Canaccord Genuity Group: 13,325,000. 18.67% Richard Jeffery: 9,825,750. 13.77% Gresham House: 5,505,000. 7.71% Neil Bentley: 5,060,400. 7.09% Pershing Securities: 4,232,422 5.93% River Global: 3,510,220. 4.92% Herald Investment Mgt: 3,335,522. 4.67% Schroder Investment Mgt: 3,334,123. 4.67% Liontrust Asset Mgt: 3,049,857. 4.27% Top 9 Shareholders: 47,841,107: 71.7% | masurenguy | |
13/9/2024 15:12 | "Still undervalued and its a super high quality business" Brendan Gulston, Gresham House. AOM cover starts at 18.15. | masurenguy | |
09/9/2024 08:53 | AOM mentioned.... The Long and Short of IT - 9/9/24 Agentic Workflows: Cornered the debate There was among the panelist a ‘we are at the beginning’ consensus. There was a positive view on AIs opportunity to unlock more creativity and free-up staff from the mundane, i.e. the Co-Pilot principle as work is dominated by repetitive language tasks. Yet after a year of AI pitches the VCs are battle-hardened, and now need evidenced-based ROI. The conversation led to the UK being ‘better’ at the AI application layer, rather than tools or infrastructure. We have supported the idea of RAG-AI whereby vertically-focused companies create ROI (our list is Relx: for Legal, Government, science and medical vertical markets analytics; Pearson: Ed-tech; LSE: Capital markets; Capita: Government Services; Moneysupermarket.com In the intervening period traditional Enterprise and SaaS companies have been ‘AI-ifying/was Agentic Workflow is a new way of interacting with and completing tasks using LLMs. These are AI agents who perform tasks in a dynamic and iterative manner. As such they differ from the approach where the agent performs a specific task on pre-defined rules. By contrast, agentic AI is autonomous agents that can perform tasks, make decisions, and interact with their environments independently and can set goals, plan, and learn. These are in development at ‘classic&rsquo We remind institutional investors of UiPath (below), but also ActiveOps also adding greater automation, and dare we say ‘agency’ | simon gordon | |
29/8/2024 15:25 | mginvestor - you would appear to be right about Calculus. Don't know about any further reduction by Schroders - they last reduced their position by circa 25% back in May this year. Anyway there should a further RNS on disposal issued in due course. "Calculus invested £4.7m in ActiveOps in 2014. Calculus has maintained a seat on the board throughout the last seven years and has supported the company through three acquisitions. Calculus has exited 75% of the holding at 6x return for investors." | masurenguy | |
29/8/2024 14:05 | Was the Calculus stake. BGF a good catch - supportive, long term etc. | rambutan2 | |
29/8/2024 13:19 | Hi Measureguy, We find out today that it is BGF (Pershing) which bought into AOM. Good to see that it was taken off another institution at a good price. I think it's actually Calculus Capital, a PE, that offloaded as they had ~4.27m (~5.9%) of AOM. But Schroders were also reducing albeit they have less shares. We'll find out soon I'm sure. Looking forward to trading updates/results. FCs are for strong FY25 profitability numbers | mginvestor | |
28/8/2024 15:18 | Looks like a large trade this morning - 4,232,422 shares sold @131.934p and then bought @132.0p at circa 10.30 this morning. Assume that the sale is by Canaccord Genuity. No impact on the share price but as this constitutes just under 6% of the issued shares there should be an RNS in due course. | masurenguy | |
12/8/2024 07:41 | Momentum here resumes ! 😎 | masurenguy | |
08/8/2024 09:08 | Hardly a ripple in the shareprice during the recent market volatility. Still around their 28 month high ! | masurenguy | |
31/7/2024 08:46 | Shareprice up almost 100% since I first invested in May 22 and has now also hit a 28 month high. | masurenguy | |
17/7/2024 09:29 | Nice move up again today on a very small trading volume. The shareprice is now up 16.5% over the past two weeks and has also just hit a 2 year high ! 😊 | masurenguy | |
06/7/2024 22:44 | I’ve got quite a few as well. The P/e ratio is alway bonkers when breaking into profit - the test is whether forecasts are realistic. I guess thats where the opportunity lies. If people look and dismiss it on current valuation grounds and the gearing works out, they’ll wonder why the share price kept rising. The level of ARR is sort of like an annuity for a business. Its what Amazon are constantly trying to do by telling us that Prime is some sort of exclusive benefit when a few million people subscribe. Its all SaaS, although I’d rather it works for AOM than for the tax-avoiding parasites. | yump | |
05/7/2024 15:41 | Thanks 18BT - The concern over valuation is only because they didn't check what the forecasts for FY25 & FY26 were BEFORE the results came out. Brokers have increased significantly the profitability forecasts (EBITDA, EBIT, PBT, EPS) for the next 2 years after the results announcement. They had 2 brokers and now a 3rd has joined them. Operational leverage will kick in now and expect margin expansion too. The real measure is the ARR which should continue to grow 10-20%. I put my money where my mouth is and bought AOM as declared on X. It is currently just over 7% of my portfolio. The senior management team here is one to back IMO. DYOR ATB | mginvestor | |
05/7/2024 15:01 | Good write up in IC and in their podcast - worth listening to. Concern is only around valuation. | 18bt | |
04/7/2024 09:58 | Will take a look - missed it somehow | yump | |
04/7/2024 09:29 | Investor Meet presentation is well worth watching. Richard is a good presenter and lots of information as to how the product will develop and why they have confidence in increasing the sales resource and confidence in landing new customers. Some very knowledgeable and good questions! | 18bt | |
03/7/2024 08:00 | Very subdued in the small co market but will be sitting on this for a few years. If they can get new sales quicker there could be some surprising profit figures in due course. This Saas model recurring revenues are very high and if customers are effectively locked in, the whole thing will compound. I’m not sure how unique the offering is yet, or how easy it is to sell, but for an early stake not sure that matters going on the figures. I wonder if this is the low point for small floated companies - gloom - uncertainty - costly debt (not here obviously!). They all suffer regardless. | yump | |
03/7/2024 06:15 | Looking good - sales up 9%, increase in margins, fantastic cash conversion, net cash up 14% and into profit ! Results for the year ended 31 March 2024 Double digit ARR growth and sustainable profit before tax provide strong basis for expansion ActiveOps plc (AIM: AOM), a leading provider of Decision Intelligence software for service operations, is pleased to announce its audited results for the year ended 31 March 2024. . ARR growth of 11% (14% constant currency) against prior year · Total Revenue growth of 5% (9% constant currency), delivering total revenue of £26.8m, driven primarily by increased recurring SaaS revenues · Gross profit margins increased to 84%, (2023: 82%) supported by a heavier SaaS to T&I revenue mix · Strong increase in adjusted EBITDA3 to £2.4m (2023: £0.7m), including an increase in capitalised development spend as the Group continues to focus on the development of advanced AI-based product features and prudent cost management · Healthy operating cash conversion4 of 175% (2023: 486%) arising from annual-in-advance billing · Sustainable profit before tax of £1.0m (2023: loss of £0.2m) · Balance sheet remains strong with £17.6m cash and cash investments5 (2023: £15.4m) and remains debt free Operational Highlights . Strong expansion across existing customers resulting in Net Revenue Retention2 (NRR) of 107%, (110% on a constant currency basis (2023: 110%)) · 82% of customers increased or maintained ARR, including 27% who increased ARR by 20% or more · Three new customers secured, each with significant expansion potential · The upsell of Series 3 for ControliQ continues to go well · Momentum in CaseWorkiQ continues to build, with total CaseWorkiQ ARR growth of 95% · Three significant ControliQ enterprise contracts secured following thorough and competitive RFP processes, as each enterprise saw the benefits of the proven enterprise-scale capabilities of ControliQ and an ability to deliver material cost savings with rapid ROI · Expansion of the Senior Leadership Team has brought additional, valuable experience and will provide increased focus on the execution of ActiveOps' growth strategy Outlook · Trading in the first few months of FY25 has been in line with the Board's expectations, driven by customer expansions and the addition of a new customer with significant expansion potential · Exciting product roadmap, including release in FY25 of ControliQ Series 4, incorporating further AI and Machine Learning features · Results of the prior period investment in product development and marketing give the Board confidence to make disciplined and focused investment in the global sales operation in the coming year to look to accelerate organic growth rate ActiveOps CEO, Richard Jeffery commented: "As we look back on FY24, and consider the way ahead, we do so with an increased sense of confidence. The investments into our product and marketing capabilities are delivering demonstrable returns, particularly in terms of strong expansion with existing customers and high retention rates. The ability of our products to blend AI and human intelligence with information drawn from other applications to deliver powerful insights is resonating more than ever. The strength of our balance sheet and growth in profitability means we are now well placed to invest into our global sales operation to replicate our success on a wider basis, aiming to drive further growth across all our key markets." | masurenguy | |
14/6/2024 06:06 | Results for the year ended 31 March 2024 are due on Wednesday 3 July 2024. | masurenguy | |
19/5/2024 12:45 | Some interesting volume trades on Friday afternoon. | masurenguy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions